CareDx acquires organ transplant supply chain firm MediGO, no terms

CareDx announced the acquisition of MediGO, “in a strategic move to expand its digital health portfolio to serve the organ procurement organization, OPO, market while also bolstering its pre-transplant offerings aimed at shortening transplant wait times and increasing access to donated organs. “MediGO shares our patient-centric mission to improve the transplant journey and brings a wealth of expertise to CareDx. By leveraging our combined strengths, we will drive operational efficiencies, accelerate innovation, and deliver even greater value to the transplant ecosystem by addressing the serious organ transplant shortage,” said Reg Seeto, CEO and President of CareDx. “The MediGO acquisition is in line with our mission, long-term growth strategy, and we’re excited to invest in this best-in-class offering that is well-proven and rapidly gaining adoption.”